Switch to:
More From Other Websites
ALEXION PHARMACEUTICALS INC Financials Feb 22 2017
Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: 2016 By the Numbers : February 21, 2017 Feb 21 2017
Alexion Halts Rare-Disease Drug SBC-103 Program Feb 20 2017
Forget Alexion, Buy these 4 Biotech Stocks Instead Feb 20 2017
Tough U.K. Line on Rare-Disease Drugs Stirs Concern After Brexit Feb 20 2017
Barron's Picks And Pans: General Motors, Hess, Biotechs And More Feb 19 2017
Alexion Pharmaceuticals, Inc. (ALXN) Suffers Another Blow In The UK Feb 17 2017
Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17,... Feb 17 2017
[$$] Takeover Candidate Alexion Is on the Mend Feb 17 2017
Edited Transcript of ALXN earnings conference call or presentation 16-Feb-17 3:00pm GMT Feb 16 2017
Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y Feb 16 2017
Alexion's 'Meh' 2017 Guide Soothes Worries Of Decline, But PNH Drug Key Feb 16 2017
Alexion (ALXN) Misses on Q4 Earnings and Revenues Feb 16 2017
Alexion Needs New Bets Feb 16 2017
Alexion Pharma's revenue forecast allays investor fears Feb 16 2017
Alexion Pharma's revenue forecast allays investor fears Feb 16 2017
Alexion 4Q Earnings of $1.26 a Share Beats Street Feb 16 2017
Alexion’s Kanuma Drug Denied UK Approval Feb 16 2017
Alexion Pharma's Bloated Blockbuster Deal Still Haunts Feb 16 2017
How Alexion’s Pipeline Is Driving Earnings Feb 16 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK